Prescription Required
Cipvildin M 500mg/50mg Tablet 15s
₹157₹102
Similar Medicine Of Cipvildin M 500mg/50mg Tablet 15s
Discover the Benefits of ABHA Card registration
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHAIntroduction to Cipvildin M 500mg/50mg Tablet 15s
Cipvildin M 500mg/50mg Tablet 15s is a blend of two antidiabetic medications, Metformin and Vildagliptin. This combination aims to effectively manage Diabetes Mellitus type 2.
- Metformin reduces liver sugar production, slows sugar absorption, and enhances insulin sensitivity.
- Vildagliptin boosts insulin release and reduces blood sugar increasing hormones, achieving better control over fasting and after-meal sugar levels when used in combination.
- Monitoring blood glucose regularly, assessing kidney function, and watching for signs of lactic acidosis (muscle pain, respiratory distress), are crucial precautions.
How Cipvildin M 500mg/50mg Tablet 15s works
Cipvildin M 500mg/50mg Tablet 15s combines two antidiabetic drugs: Metformin and Vildagliptin. Metformin reduces sugar production in the liver, slows down sugar absorption from the intestines, and makes the body more responsive to insulin. Vildagliptin increases insulin release from the pancreas and reduces hormones that raise blood sugar, leading to better control of both fasting and after-meal sugar levels when used together.
How To Use Cipvildin M 500mg/50mg Tablet 15s
- Always consult your doctor before using it and adhere to their prescribed dose and duration.
- Ingest the tablet whole; avoid chewing, crushing, or breaking.
- It is meant to be taken after food.
- Strict adherence to the prescribed dose and treatment duration is essential for effectiveness.
Special Precautions About Cipvildin M 500mg/50mg Tablet 15s
- Monitor blood glucose regularly.
- Assess kidney function before and during treatment.
- Watch for signs of muscle pain, respiratory distress.
- Inform healthcare provider of any unusual symptoms.
Benefits Of Cipvildin M 500mg/50mg Tablet 15s
- Provide comprehensive control over blood glucose levels.
- Enhances insulin sensitivity and support insulin secretion.
- Minimizes the risk of hypoglycemia, ensuring safer diabetes management.
Side Effects Of Cipvildin M 500mg/50mg Tablet 15s
- Nausea
- Vomiting
- Diarrhea
- Flatulence
- Low blood sugar
- Upset stomach
What If I Missed A Dose Of Cipvildin M 500mg/50mg Tablet 15s
- If you forget a dose of the medicine take it promptly. But if your next dose is near, skip the missed one.
- Avoid doubling up. Stick to your regular schedule for safe and effective use.
- Consult your healthcare provider with concerns. Doubling the dose is not recommended, ensuring proper adherence to your prescription for optimal outcomes.
Drug Interaction
- Pain killers- Ibuprofen, aspirin, and celecoxib
- Throid hormones- Thyroxine
- Certain drugs that affect nervous system
- Blood pressure-lowering pills- Captopril, lisinopril, enalpril, and nifedipine
- Antacid- Cimetidine
Drug Food Interaction
- Alcoholic beverages
Disease Explanation
Diabetes Mellitus type 2 - Either the body stops producing enough insulin, or there is resistance to insulin action.
Safety Advice for Cipvildin M 500mg/50mg Tablet 15s
- Moderate risk
- High risk
- Safe
Alcohol should generally be avoided while taking these medications because it can enhance their blood sugar-lowering effects and raise the risk of hypoglycemia.
It is also generally considered safe to use while pregnancy. However, it's essential to consult with a healthcare professional before using it during breastfeeding.
It is typically considered safe to use during breastfeeding. However, it's essential to consult with a healthcare professional before using it during breastfeeding.
The medication is mainly eliminated through the kidneys and can, in rare instances, cause lactic acidosis, particularly in those with kidney issues.
It is generally safe for liver. However, consult the doctor before use.
It's safe to drive after taking this drug.
Written By
Rakshita Garg
Content Updated on
Tuesday, 29 October, 2024
